Cargando…

The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD

The COVID-19 pandemic had a monumental impact on the inflammatory bowel disease (IBD) community. At the beginning of the pandemic, knowledge on the effect of SARS-CoV-2 on IBD was lacking, especially in those with medication-suppressed immune systems. Throughout the pandemic, scientific literature e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaplan, Gilaad G, Kuenzig, M Ellen, Windsor, Joseph W, Bernstein, Charles N, Bitton, Alain, Coward, Stephanie, Jones, Jennifer L, Lee, Kate, Murthy, Sanjay K, Targownik, Laura E, Peña-Sánchez, Juan-Nicolás, Ghandeharian, Sara, Rohatinsky, Noelle, Weinstein, Jake, Jones May, Tyrel, Browne, Mira, Jannati, Nazanin, Tabatabavakili, Sahar, Im, James H B, Meka, Saketh, Vukovic, Sonya, Davis, Tal, Goddard, Quinn, Gorospe, Julia, Stocks, Taylor, Caplan, Léa, Kanaan, Najla, Stuart, Daniel, Ramsay, Tesa, Robinson, Kelly J, Charron-Bishop, Diane, Benchimol, Eric I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478806/ https://www.ncbi.nlm.nih.gov/pubmed/37674494 http://dx.doi.org/10.1093/jcag/gwad019

Ejemplares similares

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors
por: Shaffer, Seth R, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs
por: Kuenzig, M Ellen, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs
por: Kuenzig, M Ellen, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD
por: El-Matary, Wael, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease
por: Targownik, Laura E, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary
por: Windsor, Joseph W, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease
por: Graff, Lesley A, et al.
Publicado: (2023)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD
por: Bernstein, Charles N, et al.
Publicado: (2021)

A210 THE BURDEN OF IBD HOSPITALIZATION IN CANADA: AN ASSESSMENT OF THE CURRENT AND FUTURE BURDEN IN A NATION-WIDE ANALYSIS
por: Coward, S, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape
por: Murthy, Sanjay K, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over Time
por: Coward, Stephanie, et al.
Publicado: (2021)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care
por: Mathias, Holly, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

A213 UNDERSTANDING PATIENT AND PHYSICIAN ATTITUDES AND EXPECTATIONS REGARDING IDENTIFYING AND MANAGING ANXIETY AND DEPRESSION IN IBD
por: Patel, A, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE
por: Ricciuto, Amanda, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
por: Graff, Lesley A, et al.
Publicado: (2021)

Costs of missed work among employed people with inflammatory bowel disease: a cross-sectional population-representative study.
por: Kuenzig, Ellen, et al.
Publicado: (2022)

A188 INFORMING IMMUNOCOMPROMISED POPULATIONS: AN EFFECTIVE AND EFFICIENT COVID-19 KNOWLEDGE TRANSLATION STRATEGY
por: Windsor, J W, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD
por: Bernstein, Charles N, et al.
Publicado: (2019)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care
por: Jones, Jennifer L, et al.
Publicado: (2021)

A220 ONTARIO POPULATION TRENDS IN INTESTINAL AND EXTRA-INTESTINAL CANCERS OVER 25 YEARS AMONG PERSONS WITH INFLAMMATORY BOWEL DISEASES AND MATCHED CONTROLS
por: Murthy, S K, et al.
Publicado: (2023)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
por: Targownik, Laura E, et al.
Publicado: (2021)

Stakeholder Perspectives on Access to IBD Care: Proceedings From a National IBD Access Summit
por: MacDonald, Sonja, et al.
Publicado: (2022)

Patient-Centered Access to IBD Care: A Qualitative Study
por: Heisler, Courtney, et al.
Publicado: (2022)

A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS
por: Coward, S, et al.
Publicado: (2023)

A35 FORECASTING THE INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASE: A CANADIAN NATION-WIDE ANALYSIS
por: Coward, S, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada
por: Rose, Keeley L, et al.
Publicado: (2019)

A26 DECONSTRUCTING DISTRESS: STAKEHOLDER ENGAGEMENT FOR EVIDENCE-BASED, PATIENT-CENTERED INTERVENTIONS FOR THE MANAGEMENT OF IBD-ASSOCIATED PSYCHOLOGICAL DISTRESS
por: Heisler, C, et al.
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
por: Murthy, Sanjay K, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
por: Benchimol, Eric I, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn’s and Colitis Canada
por: Benchimol, Eric I, et al.
Publicado: (2019)

Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
por: Kaplan, Gilaad G, et al.
Publicado: (2022)

Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study
por: Buie, Michael J, et al.
Publicado: (2023)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy
por: Kaplan, Gilaad G, et al.
Publicado: (2021)

Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
por: Kuenzig, M. Ellen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8shit3uuqvqq7ns2fi0aptfsms